Skip to main content
. 2016 Dec 19;40(2):153–167. doi: 10.1007/s40264-016-0486-x

Table 1.

Characterization of eight hepatic cyst infection episodes in seven patients during the DIPAK-1 Study

Case (episode) Age (years)/sex Lanreo-tide treat-ment (months) and dosage (mg) Cyst infec-tion history Clinical findings Maximum serum CRP (mg/L) Liver panel Additional investigations Cyst infection treatment Antibiotic treatment duration (days) Hospital admission (days)
1 (1) 46/M 3, 120 No Fever (38.7 °C) RUQ abdominal pain
Mild diarrhea
584↑ AST 37
ALT 32 ALP 69 GGT 50 Bili 10 (tot)
Imaging
Chest radiograph/
USG-abdomen/MRI-abdomen: unremarkable
18F-FDG PET/CT: two hepatic cysts showing signs of infection
Cultures
Urine: negative
Blood: E. coli
Cyst aspirate: pus, no pathogen isolated
Antibiotic
Cefuroxime 750 mg/metronidazole 500 mg, three times daily (2 days)
i.v. gentamicin 300 mg bolus (three times in 1 week)
Ciprofloxacin 500 mg twice daily (44 days)
Amoxicillin 500 mg/clavulanic acid 125 mg (20 days)
Invasive
Cyst aspiration of hepatic cyst in liver segment VIII (day 9) and of hepatic cyst in liver segment VI (day 14)
48 30
1 (2) 46/M 5, 120 Yes, case 1 Fever (38.9 °C)
RUQ abdominal pain
190↑ N/A Imaging
MRI-abdomen: unremarkable
Cultures
Urine: negative
Blood: negative
Antibiotic
i.v. ceftriaxone 2000 mg once daily (5 days)
Ciprofloxacin 500 mg twice daily (13 days)
20 6
2 51/F 5, 120 No RUQ abdominal pain
Nausea
Vomiting Fever (38 °C)
329↑ AST 29 ALT 27 ALP 57 GGT 39 Bili 11 (tot) Imaging
CT-abdomen: unremarkable
18F-FDG PET/CT: two hepatic cysts showing signs of infection
Cultures
Blood: E. coli
Antibiotic
i.v. piperacillin/tazobactam 4000 mg three times daily (3 days)
Ciprofloxacin 500 mg twice daily (13 days)
16 3
3 54/F 5, 120 No Fever (39.6 °C)
Cold shivers
No pain
245↑ AST 36 ALT 62↑ ALP 119↑ GGT 83↑ Bili 15 (indirect)
Bili 8 (direct)
Imaging
USG-abdomen: sludge in gallbladder
Cultures
Urine: negative
Blood: E. coli
Antibiotic
i.v. cefuroxim 750 mg three times daily (3 days)
Ciprofloxacin 500 mg three times daily (11 days)
14 3
4 55/F 2, 120 Hepatic RUQ abdominal pain
Fever (38.9 °C)
N/A AST 17 ALT 19 ALP 52 GGT 39 Imaging
Chest radiograph/
USG-abdomen/
CT-abdomen: unremarkable.
Repeated chest radiograph: right sided atelectasis or pneumonia
18F-FDG PET/CT: unremarkable
Cultures
Blood: negative
Antibiotic
Ciprofloxacin 500 mg twice daily (2 days)
i.v. meropenem 2000 mg and vancomycin 1000 mg (day 2)
Ampicillin-tazobactam 1500 mg once daily (2 days)
Amoxicillin/clavulanic acid twice daily (90 days)
90 4
5 56/F 3, 120 Hepatic Abdominal pain
Loss of appetite
No fever
156↑ AST 16
ALT 15 ALP 123↑
GGT 106↑
Imaging
18F-FDG PET/CT: signs of a hepatic cyst infection
Cultures
Urine: negative
Blood: negative
Antibiotic
i.v. cefuroxim/metronidazole (day 1)
Ciprofloxacin (80 days)
81 3
6 49/F 2, 90 No Fever (38.3 °C)
Cold shivers Diarrhea
Abdominal cramps and pain
105↑ AST 24 ALT 21 ALP 150↑ GGT 230↑
Bili 20 (tot)↑
Bili 13↑ (direct)
Imaging
Chest radiograph/
USG-abdomen: unremarkable
Contrast-MRI-abdomen: both kidneys show signs of cyst bleed
Cultures
Urine: negative
Blood: negative
Antibiotic
Ciprofloxacin 500 mg twice daily (42 days)
42 5
7 57/M 19, 120 No Fever (39.8 °C) Diarrhea Vomiting
Flank pain Headache
131↑ AST 23 ALT 22 ALP 71 GGT 35
Bili 6 (indirect)
Bili < 5 (direct)
Imaging
Chest radiograph/
USG-abdomen: unremarkable
Cultures
 Urine: negative
 Blood: E. coli
Antibiotic
i.v. ceftriaxone 2 g bolus (day 1)
i.v. ceftriaxone 2 g once daily (2 days)
Ciprofloxacin 500 mg twice daily (42 days)
44 3

Reference values: all cases CRP < 5 mg/L

Case 1, 3, 6: Bili total < 17 µmol/L; Bili direct < 5 µmol/L. Women: AST < 31 U/L; ALT < 34 U/L; ALP < 98 U/L; GGT < 38 U/L. Men: AST < 35 U/L; ALT < 45 U/L; ALP < 115 U/L; GGT < 55 U/L

Case 2: Bili total < 17 µmol/L; Bili direct < 5 µmol/L; AST < 40 U/L; ALT < 45 U/L; ALP < 120 U/L; GGT < 40 for men and < 55 U/L for women

Case 4, 5, 7: Bili total < 17 µmol/L; Bili direct < 5 µmol/L. Women: AST < 30 U/L; ALT < 35 U/L; ALP < 100 U/L; GGT < 40 U/L. Men: AST < 35 U/L; ALT < 45 U/L; ALP < 115 U/L; GGT < 55 U/L

ALT alanine aminotransferase, ALP alkaline phosphatase, AST aspartate aminotransferase, Bili bilirubin, CI cyst infection, CT computed tomography, E. coli Escherichia coli, eGFR estimated glomerular filtration rate, F female, GGT gamma-glutamyl transferase, i.v. intravenous, M male, MRI magnetic resonance imaging, N/A not available, RUQ right upper quadrant, TKV total kidney volume, TLV total liver volume, tot total, USG ultrasonography, 18 F-FDG PET/CT 18fluorodeoxyglucose positron-emission computed tomography, ↑ laboratory values above reference values